Anne McDonald Pritchett, PhD, is the founder of Pritchett Policy Associates, LLC, which provides life sciences, policy, advocacy, and strategic communications expertise to bear to address public policy challenges. She is a leading expert on the biopharmaceutical manufacturing supply chain and the range of public policies impacting biomedical innovation including intellectual property, cybersecurity, STEM, and economic and regulatory policies. She was previously senior vice president, Policy and Research and Member Relations, at the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the leading research-based biopharmaceutical companies. In her nearly two decades at PhRMA, she played a key role in developing and advancing research, public policies, and advocacy strategies to foster a favorable environment for continued medical innovation, maintain U.S. global leadership in medical innovation, respond to Covid-19 and prepare for future pandemics, and support globally resilient and secure manufacturing supply chains. She also has been a frequent presenter on industry-related issues, including testifying before Congress. Prior to PhRMA, she held various policy roles in the White House Office of National Drug Control Policy with a primary focus on developing the National Drug Control Strategy and Budget and managing research collaborations with the Counter-Drug Technology Assessment Center, the National Institute on Drug Abuse, and the National Academies of Science. She previously held leadership positions at a nonprofit association and several contract research firms focused on research and communications support to several federal agencies, including the National Institutes of Health as well as the National Institute of Justice.
